You hear a lot about the cost of medicines but the truth is most of us don't take enough of them. Statins, for example, would probably benefit most of us over 50 but they're given only to those with high cardiovascular risks. Pneumococcal vaccines would certainly benefit all adults over 50 but they're usually not recommended until you reach 75 or … [Read more...] about Vitamin supplements kill but get $27 billion a year in US consumer spending
Archives for June 2013
Of course, this is not quite how Pharmafutures 5 puts it but it's what they seem to be suggesting and I think they're right. Here's how they put it, "today’s binary decision making at the point of regulatory approval and price setting would need to be replaced by iterative, dynamic decision-making that adapts as evidence is accrued, and value … [Read more...] about International thinktank calls for backroom deals between regulators, payers and pharma
The Economist does it usual shilly-shallying in reporting the latest UN World Population Prospects, focussing (as it always does) on the ageing of the population rather than on the massive social, environmental and security challenges posed by a global population of over 11 billion by 2100, according to the latest revision of the UN's medium … [Read more...] about 11 billion people? No problem
According to this piece in The Independent, the British government and the Wellcome Trust want stringent new penalties for universities with researchers who publish fraudulent or misleading research. Fraud may be putting at risk the UK's place in global biomedical research. According to the piece, "retractions of medical claims alone in 2013 - … [Read more...] about Are university frauds threatening the UK’s research standing?
In the wake of the Ranbaxy scandals (see this post on our sister site, Health Issues India), multinational pharma is predicting doom for India's generics industry. This well-written piece by former Canadian politician (and former PhRMA staffer) Chris Ward comes from the latest Pharmaceutical Executive. You would not expect Ward to take a charitable … [Read more...] about Multinational pharma goes on the offensive against Indian generics
Barack Obama is making speeches on climate change and promising that it will be one of his legacy issues but he is dodging difficult decisions in US states that burn a lot of coal, according to The Christian Science Monitor . "The president should now visit those places heavily dependent on coal and try better persuasion ... it would also address … [Read more...] about Is President Obama hypocritical on climate change?
A report in yesterday's New York Times shows a dramatic drop in the prevalence of human papilloma viruses amongst teenage American girls over the past decade. HPV causes cervical cancer and genital warts. Experts ascribe the drop to the use of the HPV vaccine. In fact, the drop is steeper than predicted because the minority of girls using the … [Read more...] about Mum, why did I have to get cervical cancer? “There was a vague sense of controversy about the vaccine”
Lucy Morgan Edwards, a former Economist correspondent, was interviewed on the BBC this morning and painted a very pessimistic picture. The US (and the UK) she argued have agreed to speak to the Taliban without preconditions because Pakistan will not allow the withdrawal of troops and materiel over its territory without a deal. The Taliban, she … [Read more...] about Are negotiations with the Taliban really just surrender talks?
The American online magazine, Slate, ran an article on the ill-informed anti-vaccine views of Robert F. Kennedy Jr. He had his representative call and complain. Slate followed up and discovered that RFK had misrepresented the views of experts and repeated untruths about vacine safety. It's an enjoyable read . Let's hope other anti-vaccine … [Read more...] about When the powerful complain, editors usually roll over. Not on this vaccines story
Brazil has often done a wonderful job of hyping its public health system but beneath the hype, it's less good. Earlier this year, I spoke at an Indo-US Summit on Child Survival at which a WHO expert held up the Brazilian model. There are successes (AIDS, for example) but also bloated public sector enterprises full of political appointees which keep … [Read more...] about Brazils street protesters demand more spending on health